Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study.

Tanja Böhme,Thomas Zeller, Mehdi H Shishehbor,Martin Werner,Marianne Brodmann,Helen Parise,Andrew Holden,Michael Lichtenberg, Sahil A Parikh, Vikram S Kashyap,Cody Pietras,Daniela Tirziu,Ulrich Beschorner, Prakash Krishnan,Khusrow A Niazi,Andreas U Wali,Alexandra J Lansky

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists（2023）

Cited 0|Views11

No score

Abstract

This substudy of the Chocolate Touch Study demonstrated similar safety and efficacy for treatment of femoropopliteal disease of the Chocolate Touch DCB compared with the Lutonix DCB regardless of diabetes (DM) status at 12 months. Endovascular therapy has become the therapy of choice for the treatment of most symptomatic femoropopliteal lesions regardless of DM status. These results give clinicians another option when treating femoropopliteal disease in this high-risk patient population.

Translated text

Key words

Chocolate Touch, drug-coated balloon, paclitaxel, peripheral artery disease, diabetes mellitus

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined